Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05263076 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI)

StatusRecruiting
PhaseNot applicable
SponsorJohn Goss
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv8
  2. Site contact updatedv7
  3. Site contact updatedv6
  4. Re-verified, no change to tracked fieldsv5
  5. Start date changed from estimate of Jun 2022 to Jun 3, 2022v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Apr 2022 to Jun 2022
    • Site contact updated
    • Eligibility criteria shortened, about 5 words
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 2022 to Apr 2022
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Absolute Uterine Factor Infertility (AUFI) is due to congenital or surgical absence of a uterus or the presence of a nonfunctional uterus. Until 2014, the only option for women affected by Absolute Uterine Factor Infertility (AUFI) was adoption or surrogate motherhood. Uterine transplant is a new form of transplant to treat AUFI. The technique of uterus transplant was developed in Sweden with the transplantation of the uterus from a living donor to a woman affected by AUFI. Approximately 80 uterine transplantations have been performed, more than 50 of which have occurred within the past 3 years. To date, 34 children have been born from mothers who have received a living donor uterine transplant. This is a prospective study to treat Absolute Uterine Factor Infertility (AUFI) through uterine transplantation utilizing a uterus from a living or deceased donor resulting in live birth. A total of 10 biologically female (XX Karyotype) subjects will receive a uterine transplant.
Trial Details
NCT Number NCT05263076
Lead Sponsor John Goss
Conditions
(from sponsor)		 Mayer Rokitansky Kuster Hauser Syndrome, Absence of Uterus, Infertility of Uterine Origin
Related terms Infertility, Mullerian aplasia
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov